Plomer A and Tsarapatsanis D, Asymmetry of Human Dignity as a ‘The Fundamental Value and Constitutional Right in Europe’ in Zaccardi G (ed), Global Community Yearbook of International Law and Jurisprudence 2012 edition (OUP 2012) Porter G and others, patentability of human embryonic stem cells in Europe’ ‘The (2006) 24 Nature Biotechnology 653 Public and Corporate Economic Consultants, Strengthening the Contribution of English Higher Education Institutions to the Innovation System: Knowledge Exchange and HEIF Funding. A report for HEFCE (PACEC 2012) Public Patent Foundation, Opening Brief of Appellant in Consumer Watchdog v WARF (2013) Stem Cell Patents’ <> accessed 13 April 2014 –––, ‘WARF Radder H, Deflationary, Neo-Mertonian Critique of Academic Patenting’ in Suárez ‘A M, Dorato M and Rédei M (eds), EPSA Epistemology and Methodology of Science (Springer 2010) Rai AK, Scientific Research: Intellectual Property Rights and the Norms ‘Regulating of Science’ (1999) 94 Nw UL Rev 77 Rai AK and Cook-Deegan R, beyond gene patents’ (2013) 341 ‘Moving “isolated” Science Rai AK and Sampat BN, in patenting of federally funded research’ ‘Accountability (2012) 30 Nature Biotechnology 953 RCUK, Policies: Intellectual Property’ <> accessed 11 April 2014 ‘Impact the economic impact of the Research Councils’ (2007) <> accessed 23 –––, ‘Increasing April 2014 to Impact’ <> accessed 10 April 2014 –––, ‘Pathways Policy and Guidelines on Governance of Good Research Conduct’ (2013) –––, ‘RCUK <> accessed 07 April 2014 Review of the UK National Stem Cell Network (UKNSCN) A full - –––, ‘RCUK survey results <> accessed 05 April 2014 ’ and Conditions of Grants (2013) <> accessed 10 April 2014 –––, ‘Terms ’ REF2014, Research Outputs (REF2)’ <> accessed 07 April 2014 ‘FAQs: 01.2011 Decisions on assessing research impact’ (2011) <> –––, ‘REF 2014 Citation data’ <> accessed 07 2014 –––, ‘REF Excellence Framework’ <> accessed 23 April 2014 –––, ‘Research
Plomer A and Tsarapatsanis D, ‘The Asymmetry of Human Dignity as a Fundamental Value and Constitutional Right in Europe’ in Zaccardi G (ed), Global Community Yearbook of International Law and Jurisprudence 2012 edition (OUP 2012) Porter G and others, ‘The patentability of human embryonic stem cells in Europe’ (2006) 24 Nature Biotechnology 653 Public and Corporate Economic Consultants, Strengthening the Contribution of English Higher Education Institutions to the Innovation System: Knowledge Exchange and HEIF Funding. A report for HEFCE (PACEC 2012) Public Patent Foundation, Opening Brief of Appellant in Consumer Watchdog v WARF (2013) –––, ‘WARF Stem Cell Patents’ <> accessed 13 April 2014 Radder H, ‘A Deflationary, Neo-Mertonian Critique of Academic Patenting’ in Suárez M, Dorato M and Rédei M (eds), EPSA Epistemology and Methodology of Science (Springer 2010) Rai AK, ‘Regulating Scientific Research: Intellectual Property Rights and the Norms of Science’ (1999) 94 Nw UL Rev 77 Rai AK and Cook-Deegan R, ‘Moving beyond “isolated” gene patents’ (2013) 341 Science Rai AK and Sampat BN, ‘Accountability in patenting of federally funded research’ (2012) 30 Nature Biotechnology 953 RCUK, ‘Impact Policies: Intellectual Property’ <> accessed 11 April 2014 –––, ‘Increasing the economic impact of the Research Councils’ (2007) <> accessed 23 April 2014 –––, ‘Pathways to Impact’ <> accessed 10 April 2014 –––, ‘RCUK Policy and Guidelines on Governance of Good Research Conduct’ (2013) <> accessed 07 April 2014 –––, ‘RCUK Review of the UK National Stem Cell Network (UKNSCN) A full - survey results ’ <> accessed 05 April 2014 –––, ‘Terms and Conditions of Grants ’ (2013) <> accessed 10 April 2014 REF2014, ‘FAQs: Research Outputs (REF2)’ <> accessed 07 April 2014 –––, ‘REF 01.2011 Decisions on assessing research impact’ (2011) <> –––, ‘REF 2014 Citation data’ <> accessed 07 2014 –––, ‘Research Excellence Framework’ <> accessed 23 April 2014
Anna%20Hescott%20Thesis.docx